» Articles » PMID: 39695173

Systematic Review and Meta-analysis of Adverse Events in Clinical Trials of Mental Health Apps

Overview
Journal NPJ Digit Med
Date 2024 Dec 18
PMID 39695173
Authors
Affiliations
Soon will be listed here.
Abstract

Mental health apps are efficacious, yet they may pose risks in some. This review (CRD42024506486) examined adverse events (AEs) from mental health apps. We searched (May 2024) the Medline, PsycINFO, Web of Science, and ProQuest databases to identify clinical trials of mental health apps. The risk of bias was assessed using the Cochrane Risk of Bias tool. Only 55 of 171 identified clinical trials reported AEs. AEs were more likely to be reported in trials sampling schizophrenia and delivering apps with symptom monitoring technology. The meta-analytic deterioration rate from 13 app conditions was 6.7% (95% CI = 4.3, 10.1, I = 75%). Deterioration rates did not differ between app and control groups (OR = 0.79, 95% CI = 0.62-1.01, I = 0%). Reporting of AEs was heterogeneous, in terms of assessments used, events recorded, and detail provided. Overall, few clinical trials of mental health apps report AEs. Those that do often provide insufficient information to properly judge risks related to app use.

References
1.
Schlosser D, Campellone T, Truong B, Etter K, Vergani S, Komaiko K . Efficacy of PRIME, a Mobile App Intervention Designed to Improve Motivation in Young People With Schizophrenia. Schizophr Bull. 2018; 44(5):1010-1020. PMC: 6101497. DOI: 10.1093/schbul/sby078. View

2.
Klatte R, Strauss B, Fluckiger C, Rosendahl J . Adverse events in psychotherapy randomized controlled trials: A systematic review. Psychother Res. 2023; 35(1):84-99. DOI: 10.1080/10503307.2023.2286992. View

3.
Torous J, Bucci S, Bell I, Kessing L, Faurholt-Jepsen M, Whelan P . The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry. 2021; 20(3):318-335. PMC: 8429349. DOI: 10.1002/wps.20883. View

4.
Zhao C, Zhao Z, Levin M, Lai L, Shi C, Hu J . Efficacy and acceptability of mobile application-delivered acceptance and commitment therapy for posttraumatic stress disorder in China: A randomized controlled trial. Behav Res Ther. 2023; 171:104440. DOI: 10.1016/j.brat.2023.104440. View

5.
Garety P, Ward T, Emsley R, Greenwood K, Freeman D, Fowler D . Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis: A Randomized Clinical Trial. JAMA Psychiatry. 2021; 78(7):714-725. PMC: 8027943. DOI: 10.1001/jamapsychiatry.2021.0326. View